InvestorsHub Logo

1400

02/03/15 4:18 PM

#90238 RE: Rdunn88 #90235

I would rather Leo put his medical team together. Getting the right scientific people on board to me is more important than putting a BOD together for the moment.

Drano

02/03/15 7:32 PM

#90260 RE: Rdunn88 #90235

"how [to] be complacent"? Being up hugely in a few years, in a company that has not one but 3 possible blockbuster drugs, any one of whose success will triple the stock price quickly -- that's how I can be complacent when I see the stock price moving around by (choose your combination} weak hands, profit-taking, short sellers, the bored, people who get scared by trash talk, etc.

And since the CEO has a huge chunk of stock and has given some to his synagogue and would be humiliated if the company failed, I think his interests are aligned with those of the other shareholders.
There are so many bad bioteh companies out there with unpromising science or bad CEO's or both -- this isn't one of them.

biodoc

02/03/15 10:13 PM

#90264 RE: Rdunn88 #90235

I hope Leo focuses on the science while prudently managing Cellceutix's finances. Also, I hope Leo doesn't generate a reactive PR to market action that does not impact the long term value of Cellceutix. Perhaps the volatility is clouding your long term vision?

Brilacidin Phase 3 meetings, advancement of Kevetrin with p53/p21 data, B-OM (placebo control group!) trial initiation, and Prurisol Phase 2 trial initiation are relatively near-term events that may greatly improve Leo's negotiating position. Leo knows what he's doing.

frrol

02/04/15 8:24 AM

#90294 RE: Rdunn88 #90235

Investing in stocks requires patience and reason - biotech stocks perhaps most of all. Stocks never go straight up, not even the best ones. People are buying and selling all the time.